Supernus Pharmaceuticals, Inc.Supernus Pharmaceuticals, Inc.Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

39.250.000.00%
The 4 analysts offering 1 year price forecasts for SUPN have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to SUPN in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


SUPN EPS for the last quarter is 1.17 USD despite the estimation of 0.44 USD. In the next quarter EPS is expected to reach 0.50 USD. Track more of Supernus Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Supernus Pharmaceuticals, Inc. revenue is expected to reach ‪154.51 M‬ USD. Check out Supernus Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, SUPN price target is 39.25 USD with a max estimate of 43.00 USD and a min estimate of 36.00 USD. Check if this forecast comes true in a year, meanwhile watch Supernus Pharmaceuticals, Inc. stock price chart and keep track of the current situation with SUPN news and stock market news.